Marian Sobhy Waheeb Azer | Pharmaceutical Sciences | Innovative Research Award

Innovative Research Award

Marian Sobhy Waheeb Azer — Misr University for Science & Technology, Egypt

Marian Sobhy Waheeb Azer
Affiliation Misr University for Science & Technology
Country Egypt
Subject Area Pharmaceutical Sciences
Event International Top Pharmaceutical Awards
ORCID 0000-0003-1072-9893

Marian Sobhy Waheeb Azer is a researcher associated with pharmaceutical sciences whose ORCID record lists work on drug delivery, formulation development, and pharmacokinetic evaluation. The documented topics include a lamotrigine self-nanoemulsifying delivery system and a ciclopirox olamine emulgel formulation. These subjects reflect practical research interests in dosage-form design, pharmaceutical characterization, and the investigation of drug delivery performance. This article summarizes the available profile information and its relevance to the Innovative Research Award without assuming unverified bibliometric indicators or award outcomes.[1][2]

Abstract

This profile reviews the pharmaceutical research themes documented in Marian Sobhy Waheeb Azer’s ORCID record. The listed publications concern formulation development and drug delivery, including a solid self-nanoemulsifying system for lamotrigine and a topical emulgel containing ciclopirox olamine. These topics are relevant to pharmaceutical formulation, characterization, and evaluation of drug delivery systems. The available record supports a focused account of these research activities, but does not independently establish citation totals, an h-index, or an official award decision.[1][2]

Keywords

Pharmaceutical sciences; drug delivery systems; lamotrigine; self-nanoemulsifying drug delivery; pharmacokinetics; ciclopirox olamine; emulgel formulation; pharmaceutical characterization; formulation research; innovative research.

Introduction

Pharmaceutical research connects the design of dosage forms with the assessment of their properties and potential performance. Delivery-system development can investigate how formulation components influence drug solubilization, release, and absorption, while topical formulations address the requirements of local administration. Azer’s documented work sits within these broad areas. The available publication metadata provides a basis for describing the research topics, although detailed experimental results should be taken from the original articles rather than inferred from titles alone.[1][2]

Research Profile

The supplied ORCID profile identifies Marian Sobhy Azer and lists two research works. One is a 2020 journal article in Drug Design, Development and Therapy on the development, characterization, and in-vivo pharmacokinetic study of a lamotrigine solid self-nanoemulsifying drug delivery system. The other concerns the development and characterization of ciclopirox olamine emulgel for topical drug delivery, listed as published in 2014. The profile does not provide verified Scopus author metrics in the supplied document.[1][2]

Research Contributions

The lamotrigine study addresses a formulation approach designed to support drug delivery and includes characterization and in-vivo pharmacokinetic evaluation in its stated scope. Such work connects pharmaceutical development with the measurement of drug disposition, although specific outcomes require consultation of the full publication. The topical emulgel work focuses on a formulation containing ciclopirox olamine, illustrating a separate dosage-form application. Together, the listed topics show engagement with both systemic delivery research and topical formulation development.[1][2]

Publications

The ORCID profile lists two publications related to pharmaceutical sciences. One focuses on the development and evaluation of a lamotrigine drug delivery system, while the other examines the formulation and characterization of ciclopirox olamine emulgel for topical drug delivery.[1][2]

Research Impact

The documented subjects are relevant to formulation scientists and pharmaceutical researchers investigating delivery strategies and dosage-form characteristics. However, research impact should be assessed using verified evidence such as citation records, independent adoption, reproducibility, and influence on subsequent work. Citation counts and h-index values are not present in the supplied ORCID document, so no numerical impact claim is made here. Further evaluation can use indexed publication records and the full-text articles.[1][3]

Award Suitability

The listed work provides subject-matter relevance to an Innovative Research Award in pharmaceutical sciences, particularly through formulation development and drug delivery investigations. A fair assessment would examine originality, methodological quality, reproducibility, publication integrity, practical significance, and the candidate’s specific contribution to each study. The information presented here is a profile summary, not confirmation of nomination, selection, or receipt of an award. Final eligibility and recognition must be verified with the award organizer.[4]

Conclusion

Marian Sobhy Waheeb Azer’s supplied ORCID record documents research related to lamotrigine delivery systems and ciclopirox olamine topical formulation. These subjects are pertinent to pharmaceutical formulation and evaluation. The record offers a starting point for academic recognition, while a complete assessment requires the original articles, verified bibliometric data, and evidence of individual research contributions. Readers should consult the linked primary sources for publication details and the official award website for current event information.

References

  1. Azer, M. S. (2020). Development, Characterization, and in-vivo Pharmacokinetic Study of Lamotrigine Solid Self-Nanoemulsifying Drug Delivery System. Drug Design, Development and Therapy. DOI: 10.2147/DDDT.S263898.
  2. Azer, M. S. (2014). Development and Characterization of Ciclopirox Olamine Emulgel for Topical Drug Delivery. Inventi Impact: Pharm Tech. Publication details transcribed from the supplied ORCID profile. https://inventi.in/journal/article/1/7319/Inventi%20Impact:%20Pharm%20Tech/Pharmaceutical
  3. ORCID. (n.d.). Marian Sobhy Azer: Researcher record and works. https://orcid.org/0000-0003-1072-9893.
  4. International Top Pharmaceutical Awards. (n.d.). Official award website. Award eligibility and recognition details should be confirmed with the organizer. https://toppharmaceutical.org/.

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Dr. Jameel Al-Tamimi, King Saud University, Saudi Arabia

Dr. Jameel Al-Tamimi is a distinguished researcher with a Ph.D. in Immunogenetics from King Saud University, Riyadh, Saudi Arabia. His research focuses on immunology, particularly the role of Killer Immunoglobulin-like Receptors (KIRs) in leukemia. He has expertise in molecular techniques, immunology, and forensic entomology. Dr. Al-Tamimi has published numerous research articles and has contributed to various academic committees. His teaching experience spans courses in molecular biology, human physiology, and medical entomology.

Publication Profile

Google Scholar

Education

Dr. Jameel Al-Tamimi 🎓 is a distinguished researcher with a Ph.D. in Immunogenetics (Excellent 4.9/5) from King Saud University, where his thesis explored the Role of Killer Immunoglobulin-like Receptors (KIRs) with HLA Ligands in Saudi Leukemia Patients 🧬. He also holds an M.Sc. in Entomology and Parasitology (Excellent 4.9/5), investigating the anti-inflammatory effects of Pachycondyla sennaarensis (Samsum Ant) venom in male albino rats 🐜🧪. Dr. Al-Tamimi earned his B.Sc. in Biology (Very Good 89.9/100) from Thamar University, Yemen, with research focused on physiological changes in viral hepatitis (HbsAg and HCV) patients at Thamar Hospital 🧫🦠.

Experience

Dr. Jameel Al-Tamimi 🧑‍🔬 brings a wealth of academic and research experience. Since 2023, he has served on the Scientific Committee for the Researcher Support Program (RSPD) and Research Groups Program (RGP) at the Deanship of Scientific Research 📚. At King Saud University, he contributed to key committees, including labs, academic accreditation, exams, and graduate studies 🏛️. He supervised both the endocrinology and immunology laboratories 🧪 and mentored undergraduate and master’s students 🎓. Skilled in handling rats, mice, and insects 🐭🦗, Dr. Al-Tamimi is also proficient in advanced molecular biology, immunology, and physiology techniques 🧬🔬.

Awards

Dr. Jameel Al-Tamimi 🎓 has been recognized for his academic excellence with several prestigious awards. In 2015, he received an acknowledgment certificate from the Chairman of the Center of Excellence in the Development of Science and Mathematics Education at King Saud University 🏅, highlighting his contribution to scientific advancement. Earlier, in 2013, he was honored with a Certificate of Appreciation (General Prize) during the first Graduate Student Annual Scientific Meeting at KSU 📜🎉. These achievements reflect his dedication to academic excellence, innovation in research, and commitment to the scientific community 🌟📚.

Research Focus

Dr. Jameel Al-Tamimi is a multidisciplinary biomedical researcher whose primary focus lies in oxidative stress, wound healing, diabetes, and nanoparticle therapeutics. His work spans nanomedicine, immunomodulation, and natural product pharmacology, particularly in evaluating the biological activities of camel milk peptides, selenium and zinc oxide nanoparticles, and bioactive plant extracts. Dr. Al-Tamimi’s studies contribute significantly to redox biology, diabetic complications, and biofabrication of therapeutic agents, offering innovative strategies for combating chronic diseases and enhancing healing processes. 🧫💊🐫 His collaborative work reflects a strong emphasis on toxicology, regenerative medicine, and bio-nanotechnology.

Publication Top Notes

Camel milk peptide improves wound healing in diabetic rats by orchestrating the redox status and immune response

Wound healing of different molecular weight of hyaluronan; in-vivo study‏

Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress‏

Synthesis, structural characterization of silver (I)-NHC complexes and their antimicrobial, antioxidant and antitumor activities‏

Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide‏

Efficacy of a Methanolic Extract of Adansonia digitata Leaf in Alleviating Hyperglycemia, Hyperlipidemia, and Oxidative Stress of Diabetic Rats‏

Antioxidant Bioactivity of Samsum Ant (Pachycondyla sennaarensis) Venom Protects against CCL4‐Induced Nephrotoxicity in Mice‏

Biofabrication of Zinc Oxide Nanoparticle from Ochradenus baccatus Leaves: Broad‐Spectrum Antibiofilm Activity, Protein Binding Studies, and In Vivo Toxicity …‏

Mr. Yeniewa Anagaw| Pharmacy|Best Researcher Award

Mr. Yeniewa Anagaw| Pharmaceutical Pharmacy
|Best Researcher Award

Mr. Yeniewa Anagaw at Medical University of Gondar,Ethiopia

PROFILE  

scopus

Google scholar

Early Academic Pursuits 📚

Yeniewa Kerie Anagaw’s journey in academia began with his Bachelor of Pharmacy degree from Miza-Tepi University, Ethiopia, in 2016. Graduating with a commendable cGPA of 3.39/4.00, his directed study explored a critical area of public health, specifically focusing on tuberculosis treatment outcomes and predictors among HIV patients in Southwest Ethiopia. This early research demonstrated his keen interest in addressing significant health challenges affecting his community. He continued his academic growth with a Master of Science in Pharmaceutical Analysis and Quality Assurance at Addis Ababa University, where he earned an impressive cGPA of 3.81/4.00. His thesis, titled “Analytical Method Development and Validation Based on Paper Analytical Device (PAD) for Adulteration Detection in Teff Injera (Ethiopian flatbread),” highlights his dedication to innovation in pharmaceutical analysis and public health. This work, which employed Microwave Plasma Atomic Emission Spectroscopy (MP-AES), underscores his analytical and scientific rigor.

Professional Endeavors and Teaching Commitments 👨‍🏫

Yeniewa’s professional career took off in December 2016 when he joined Finote Selam General Hospital as a junior pharmacist. In this role, he participated in ward rounds and patient chart reviews, where he helped identify, prevent, and mitigate drug-related problems. His responsibilities included ensuring appropriate drug selection and dosage, managing adverse drug reactions, addressing drug interactions, and preparing compounded dermatological formulations. Yeniewa also worked as a pharmacy coordinator, showcasing his leadership and organizational skills early in his career.

By January 2018, Yeniewa transitioned into academia as an assistant lecturer at the University of Gondar’s School of Pharmacy. In this role, he supervised and instructed undergraduate students in Pharmaceutical Analysis laboratory sessions, focusing on hands-on training in instrumental analysis and data interpretation. His role expanded to delivering lectures in Pharmaceutical Analysis, Pharmacy Practice, and Quality Control and Assurance. Yeniewa’s dynamic teaching style, coupled with his passion for research, has made him a pivotal figure in shaping future pharmacists.

Since April 2022, Yeniewa has held a lecturer position at the University of Gondar. Here, his responsibilities have evolved to include not only lecture preparation and delivery but also student mentoring, exam evaluation, and practical learning experiences. Yeniewa’s teaching covers Electroanalytical Methods, IR Spectroscopy, NMR, HPLC, and Mass Spectrometry (MS), which are crucial tools in the field of pharmaceutical science. His ability to guide students through both theoretical and practical knowledge demonstrates his comprehensive approach to education.

Contributions and Research Focus 🔬

Yeniewa’s research interests span across various domains within pharmaceutical sciences, including pharmaceutical analysis, quality assurance, proteomics, metabolomics, drug delivery, and biomarker discovery. His dedication to research is reflected in his published works and his involvement in grant writing for school projects. Yeniewa is particularly passionate about developing analytical methods for drug adulteration detection, exemplified by his thesis on detecting adulterants in Teff Injera. This research is crucial for ensuring food safety and protecting public health.

Additionally, Yeniewa has participated in several community service initiatives. One notable contribution involved the quantitative analysis of table salt used for wound cleaning, showcasing his commitment to improving healthcare practices in Ethiopia. His engagement in such community-oriented projects demonstrates his desire to translate academic research into practical solutions that benefit society.

Accolades and Recognition 🏅

Throughout his career, Yeniewa has earned various certificates and recognition for his contributions to both academia and the pharmaceutical field. Some of his notable achievements include:

  • Certificate of the training workshop on “Anticancer Medicines Quality Evaluation Using the Chemo-spot System.”
  • BMJ Open Reviewer’s Certificate and Peer Reviewer Verification Certificates from Springer Nature, which highlight his contributions to scientific literature through peer review.
  • Presenter Certificate at the “42nd Annual Scientific Conference of the Ethiopia Pharmacy Association (EPA),” where he shared his research with a broader scientific community.
  • Certificates for attending workshops and training sessions on research enhancement, intellectual property, and good manufacturing practices (GMP), indicating his commitment to continuous professional development.

Impact and Influence 🌍

Yeniewa’s influence extends beyond his immediate academic and professional circles. His research on tuberculosis treatment and pharmaceutical adulteration contributes to public health advancements, particularly in Ethiopia. By addressing key issues in drug safety and treatment optimization, he has played a role in enhancing healthcare outcomes for vulnerable populations. As a lecturer, Yeniewa has directly impacted the education of future pharmacists, providing them with the knowledge and skills necessary to excel in both clinical and research settings. His involvement in grant writing and school projects also demonstrates his efforts to foster research initiatives that could have far-reaching benefits.

Legacy and Future Contributions 🌟

As Yeniewa continues his career, his focus remains on bridging the gap between pharmaceutical research and practical healthcare solutions. His expertise in proteomics, drug discovery, and spectroscopic methods positions him as a valuable contributor to ongoing efforts in pharmaceutical innovation. Furthermore, his dedication to teaching ensures that future generations of pharmacists are well-equipped to tackle emerging challenges in the field.

Yeniewa’s future contributions are likely to leave a lasting legacy, both in terms of academic excellence and practical healthcare improvements. His adaptability, hard work, and passion for both teaching and research will continue to drive his success as he navigates the evolving landscape of pharmaceutical sciences.

🎓Publication 

Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia

  • Authors   :Adane Teshome Kefale, Yeniewa Kerie Anagaw
  • Journal    :International Journal of General Medicine
  • Year         :2017

Assessment of community pharmacy professionals’ willingness, involvement, beliefs, and barriers to offer health promotion services: a cross-sectional study

  • Authors   : Wondim Ayenew, Abdulwase Mohammed Seid, Asmamaw Emagn Kasahun, Asrat Elias Ergena, Derso Teju Geremaw, Liknaw Workie Limenh, Teshome Bitew Demelash, Wudneh Simegn, Yeniewa Kerie Anagaw, L.
  • Journal    :BMC Health Services Research
  • Year         :2022

Assessment of Knowledge, Attitudes, and Practices of Traditional Healers toward Dosage Forms and Routes of Administration: A Cross‐Sectional Study in Ethiopia

  • Authors   : Liknaw Workie Limenh, Derso Teju Geremew, Asmamaw Emagn Kasahun, Yeniewa Kerie Anagaw, Minichil Chanie Worku, Wudneh Simegn, Wondim Ayenew
  • Journal    :Evidence‐Based Complementary and Alternative Medicine
  • Year         :2023

Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia

  • Authors   :Minichil Chanie Worku, Melese Legesse Mitku, Wondm Ayenew, Liknew Workie Limenh, Asrat Elias Ergena, Derso Teju Geremew, Gizachew Kassahun Bizuneh, Bereket Bahiru Tefera, Biset Asrade Mekonnen, Yeniewa Kerie Anagaw
  • Journal    :Currents in Pharmacy Teaching and Learning
  • Year         :2024

Prevalence and predictors of self-medication with antibiotics in Ethiopia: a systematic review and meta-analysis

  • Authors   :Wondim Ayenew, Tewodros Ayalew Tessema, Yeniewa Kerie Anagaw, Ebrahim Abdela Siraj, Segenet Zewdie, Wudneh Simegn, Liknaw Workie Limenh, Chernet Tafere, Ashagrachew Tewabe Yayehrad
  • Journal    :Antimicrobial Resistance & Infection Control
  • Year         :2024